Conservative  ||| S:0 E:13 ||| JJ
oxygen  ||| S:13 E:20 ||| NN
therapy  ||| S:20 E:28 ||| NN
in  ||| S:28 E:31 ||| IN
mechanically  ||| S:31 E:44 ||| RB
ventilated  ||| S:44 E:55 ||| JJ
patients  ||| S:55 E:64 ||| NNS
following  ||| S:64 E:74 ||| VBG
cardiac  ||| S:74 E:82 ||| JJ
arrest ||| S:82 E:88 ||| NN
:  ||| S:88 E:90 ||| :
A  ||| S:90 E:92 ||| DT
retrospective  ||| S:92 E:106 ||| JJ
nested  ||| S:106 E:113 ||| JJ
cohort  ||| S:113 E:120 ||| JJ
study  ||| S:120 E:126 ||| NN
In  ||| S:126 E:129 ||| IN
mechanically  ||| S:129 E:142 ||| JJ
ventilated  ||| S:142 E:153 ||| NNS
( ||| S:153 E:154 ||| -LRB-
MV ||| S:154 E:156 ||| NNP
)  ||| S:156 E:158 ||| -RRB-
cardiac  ||| S:158 E:166 ||| JJ
arrest  ||| S:166 E:173 ||| NN
( ||| S:173 E:174 ||| -LRB-
CA ||| S:174 E:176 ||| NNP
)  ||| S:176 E:178 ||| -RRB-
survivors  ||| S:178 E:188 ||| NNS
admitted  ||| S:188 E:197 ||| VBD
to  ||| S:197 E:200 ||| TO
the  ||| S:200 E:204 ||| DT
intensive  ||| S:204 E:214 ||| JJ
care  ||| S:214 E:219 ||| NN
unit  ||| S:219 E:224 ||| NN
( ||| S:224 E:225 ||| -LRB-
ICU ||| S:225 E:228 ||| NNP
)  ||| S:228 E:230 ||| -RRB-
avoidance  ||| S:230 E:240 ||| NN
of  ||| S:240 E:243 ||| IN
hypoxia  ||| S:243 E:251 ||| NN
is  ||| S:251 E:254 ||| VBZ
considered  ||| S:254 E:265 ||| VBN
crucial ||| S:265 E:272 ||| JJ
.  ||| S:272 E:274 ||| .
However ||| S:274 E:281 ||| RB
,  ||| S:281 E:283 ||| ,
avoidance  ||| S:283 E:293 ||| NN
of  ||| S:293 E:296 ||| IN
hyperoxia  ||| S:296 E:306 ||| NNS
may  ||| S:306 E:310 ||| MD
also  ||| S:310 E:315 ||| RB
be  ||| S:315 E:318 ||| VB
important ||| S:318 E:327 ||| JJ
.  ||| S:327 E:329 ||| .
A  ||| S:329 E:331 ||| DT
conservative  ||| S:331 E:344 ||| JJ
approach  ||| S:344 E:353 ||| NN
to  ||| S:353 E:356 ||| TO
oxygen  ||| S:356 E:363 ||| VB
therapy  ||| S:363 E:371 ||| NN
may  ||| S:371 E:375 ||| MD
reduce  ||| S:375 E:382 ||| VB
exposure  ||| S:382 E:391 ||| NN
to  ||| S:391 E:394 ||| TO
both ||| S:394 E:398 ||| DT
.  ||| S:398 E:400 ||| .
We  ||| S:400 E:403 ||| PRP
evaluated  ||| S:403 E:413 ||| VBD
the  ||| S:413 E:417 ||| DT
introduction  ||| S:417 E:430 ||| NN
of  ||| S:430 E:433 ||| IN
conservative  ||| S:433 E:446 ||| JJ
oxygen  ||| S:446 E:453 ||| NN
therapy  ||| S:453 E:461 ||| NN
( ||| S:461 E:462 ||| -LRB-
target  ||| S:462 E:469 ||| NN
SpO2  ||| S:469 E:474 ||| CD
88-92 ||| S:474 E:479 ||| CD
%  ||| S:479 E:481 ||| NN
using  ||| S:481 E:487 ||| VBG
the  ||| S:487 E:491 ||| DT
lowest  ||| S:491 E:498 ||| JJS
FiO2 ||| S:498 E:502 ||| CD
)  ||| S:502 E:504 ||| -RRB-
during  ||| S:504 E:511 ||| IN
MV  ||| S:511 E:514 ||| NNP
for  ||| S:514 E:518 ||| IN
resuscitated  ||| S:518 E:531 ||| JJ
CA  ||| S:531 E:534 ||| NN
patients  ||| S:534 E:543 ||| NNS
admitted  ||| S:543 E:552 ||| VBD
to  ||| S:552 E:555 ||| TO
the  ||| S:555 E:559 ||| DT
ICU ||| S:559 E:562 ||| NNP
.  ||| S:562 E:564 ||| .
We  ||| S:564 E:567 ||| PRP
studied  ||| S:567 E:575 ||| VBD
912  ||| S:575 E:579 ||| CD
arterial  ||| S:579 E:588 ||| JJ
blood  ||| S:588 E:594 ||| NN
gas  ||| S:594 E:598 ||| NN
( ||| S:598 E:599 ||| -LRB-
ABG ||| S:599 E:602 ||| NNP
)  ||| S:602 E:604 ||| -RRB-
datasets ||| S:604 E:612 ||| NN
:  ||| S:612 E:614 ||| :
448  ||| S:614 E:618 ||| CD
ABGs  ||| S:618 E:623 ||| NN
from  ||| S:623 E:628 ||| IN
50  ||| S:628 E:631 ||| CD
' ||| S:631 E:632 ||| POS
conventional ||| S:632 E:644 ||| JJ
'  ||| S:644 E:646 ||| ''
and  ||| S:646 E:650 ||| CC
464  ||| S:650 E:654 ||| CD
ABGs  ||| S:654 E:659 ||| NN
from  ||| S:659 E:664 ||| IN
50  ||| S:664 E:667 ||| CD
' ||| S:667 E:668 ||| POS
conservative ||| S:668 E:680 ||| NN
'  ||| S:680 E:682 ||| POS
oxygen  ||| S:682 E:689 ||| NN
therapy  ||| S:689 E:697 ||| NN
patients ||| S:697 E:705 ||| NNS
.  ||| S:705 E:707 ||| .
Compared  ||| S:707 E:716 ||| VBN
to  ||| S:716 E:719 ||| TO
the  ||| S:719 E:723 ||| DT
conventional  ||| S:723 E:736 ||| JJ
group ||| S:736 E:741 ||| NN
,  ||| S:741 E:743 ||| ,
conservative  ||| S:743 E:756 ||| JJ
group  ||| S:756 E:762 ||| NN
patients  ||| S:762 E:771 ||| NNS
had  ||| S:771 E:775 ||| VBD
significantly  ||| S:775 E:789 ||| RB
lower  ||| S:789 E:795 ||| JJR
PaO2  ||| S:795 E:800 ||| NN
values  ||| S:800 E:807 ||| NNS
and  ||| S:807 E:811 ||| CC
FiO2  ||| S:811 E:816 ||| CD
exposure  ||| S:816 E:825 ||| NN
( ||| S:825 E:826 ||| -LRB-
p  ||| S:826 E:827 ||| FW
< ||| S:827 E:828 ||| SYM
0.001 ||| S:828 E:833 ||| FW
,  ||| S:833 E:835 ||| ,
respectively ||| S:835 E:847 ||| RB
) ||| S:847 E:848 ||| -RRB-
;  ||| S:848 E:850 ||| :
more  ||| S:850 E:855 ||| RBR
received  ||| S:855 E:864 ||| VBN
MV  ||| S:864 E:867 ||| NNP
in  ||| S:867 E:870 ||| IN
a  ||| S:870 E:872 ||| DT
spontaneous  ||| S:872 E:884 ||| JJ
ventilation  ||| S:884 E:896 ||| NN
mode  ||| S:896 E:901 ||| NN
( ||| S:901 E:902 ||| -LRB-
18 ||| S:902 E:904 ||| CD
%  ||| S:904 E:906 ||| NN
vs  ||| S:906 E:909 ||| VBD
2 ||| S:909 E:910 ||| CD
% ||| S:910 E:911 ||| NN
;  ||| S:911 E:913 ||| :
p=0.001 ||| S:913 E:920 ||| CD
)  ||| S:920 E:922 ||| -RRB-
and  ||| S:922 E:926 ||| CC
more  ||| S:926 E:931 ||| RBR
were  ||| S:931 E:936 ||| VBD
exposed  ||| S:936 E:944 ||| VBN
to  ||| S:944 E:947 ||| TO
a  ||| S:947 E:949 ||| DT
FiO2  ||| S:949 E:954 ||| NN
of  ||| S:954 E:957 ||| IN
0.21  ||| S:957 E:962 ||| NNP
( ||| S:962 E:963 ||| -LRB-
19  ||| S:963 E:966 ||| CD
vs  ||| S:966 E:969 ||| CD
0  ||| S:969 E:971 ||| CD
patients ||| S:971 E:979 ||| NNS
,  ||| S:979 E:981 ||| ,
p=0.001 ||| S:981 E:988 ||| CD
) ||| S:988 E:989 ||| -RRB-
.  ||| S:989 E:991 ||| .
Additionally ||| S:991 E:1003 ||| RB
,  ||| S:1003 E:1005 ||| ,
according  ||| S:1005 E:1015 ||| VBG
to  ||| S:1015 E:1018 ||| TO
mean  ||| S:1018 E:1023 ||| VB
PaO2 ||| S:1023 E:1027 ||| CD
,  ||| S:1027 E:1029 ||| ,
more  ||| S:1029 E:1034 ||| RBR
conservative  ||| S:1034 E:1047 ||| JJ
group  ||| S:1047 E:1053 ||| NN
patients  ||| S:1053 E:1062 ||| NNS
were  ||| S:1062 E:1067 ||| VBD
classified  ||| S:1067 E:1078 ||| VBN
as  ||| S:1078 E:1081 ||| IN
normoxaemic  ||| S:1081 E:1093 ||| NNS
( ||| S:1093 E:1094 ||| -LRB-
36  ||| S:1094 E:1097 ||| CD
vs  ||| S:1097 E:1100 ||| CD
16  ||| S:1100 E:1103 ||| CD
patients ||| S:1103 E:1111 ||| NNS
,  ||| S:1111 E:1113 ||| ,
p  ||| S:1113 E:1114 ||| CD
< ||| S:1114 E:1115 ||| SYM
0.01 ||| S:1115 E:1119 ||| CD
)  ||| S:1119 E:1121 ||| -RRB-
and  ||| S:1121 E:1125 ||| CC
fewer  ||| S:1125 E:1131 ||| JJR
as  ||| S:1131 E:1134 ||| IN
hyperoxaemic  ||| S:1134 E:1147 ||| NNS
( ||| S:1147 E:1148 ||| -LRB-
14  ||| S:1148 E:1151 ||| CD
vs  ||| S:1151 E:1154 ||| CD
33  ||| S:1154 E:1157 ||| CD
patients ||| S:1157 E:1165 ||| NNS
,  ||| S:1165 E:1167 ||| ,
p  ||| S:1167 E:1168 ||| CD
< ||| S:1168 E:1169 ||| SYM
0.01 ||| S:1169 E:1173 ||| CD
) ||| S:1173 E:1174 ||| -RRB-
.  ||| S:1174 E:1176 ||| .
Finally ||| S:1176 E:1183 ||| RB
,  ||| S:1183 E:1185 ||| ,
ICU  ||| S:1185 E:1189 ||| NNP
length  ||| S:1189 E:1196 ||| NN
of  ||| S:1196 E:1199 ||| IN
stay  ||| S:1199 E:1204 ||| NN
was  ||| S:1204 E:1208 ||| VBD
significantly  ||| S:1208 E:1222 ||| RB
shorter  ||| S:1222 E:1230 ||| JJR
for  ||| S:1230 E:1234 ||| IN
conservative  ||| S:1234 E:1247 ||| JJ
group  ||| S:1247 E:1253 ||| NN
patients  ||| S:1253 E:1262 ||| NNS
( ||| S:1262 E:1263 ||| -LRB-
p=0.04 ||| S:1263 E:1269 ||| NNP
) ||| S:1269 E:1270 ||| -RRB-
.  ||| S:1270 E:1272 ||| .
There  ||| S:1272 E:1278 ||| EX
was  ||| S:1278 E:1282 ||| VBD
no  ||| S:1282 E:1285 ||| DT
difference  ||| S:1285 E:1296 ||| NN
in  ||| S:1296 E:1299 ||| IN
the  ||| S:1299 E:1303 ||| DT
proportion  ||| S:1303 E:1314 ||| NN
of  ||| S:1314 E:1317 ||| IN
survivors  ||| S:1317 E:1327 ||| NNS
discharged  ||| S:1327 E:1338 ||| VBN
from  ||| S:1338 E:1343 ||| IN
hospital  ||| S:1343 E:1352 ||| NN
with  ||| S:1352 E:1357 ||| IN
good  ||| S:1357 E:1362 ||| JJ
neurological  ||| S:1362 E:1375 ||| JJ
outcome  ||| S:1375 E:1383 ||| NN
( ||| S:1383 E:1384 ||| -LRB-
14 ||| S:1384 E:1386 ||| CD
/ ||| S:1386 E:1387 ||| CD
23  ||| S:1387 E:1390 ||| CD
vs  ||| S:1390 E:1393 ||| CD
12 ||| S:1393 E:1395 ||| CD
/ ||| S:1395 E:1396 ||| CD
22  ||| S:1396 E:1399 ||| CD
patients ||| S:1399 E:1407 ||| NNS
,  ||| S:1407 E:1409 ||| ,
p=0.67 ||| S:1409 E:1415 ||| CD
) ||| S:1415 E:1416 ||| -RRB-
.  ||| S:1416 E:1418 ||| .
Our  ||| S:1418 E:1422 ||| PRP$
findings  ||| S:1422 E:1431 ||| NNS
provide  ||| S:1431 E:1439 ||| VBP
preliminary  ||| S:1439 E:1451 ||| JJ
support  ||| S:1451 E:1459 ||| NN
for  ||| S:1459 E:1463 ||| IN
the  ||| S:1463 E:1467 ||| DT
feasibility  ||| S:1467 E:1479 ||| NN
and  ||| S:1479 E:1483 ||| CC
physiological  ||| S:1483 E:1497 ||| JJ
safety  ||| S:1497 E:1504 ||| NN
of  ||| S:1504 E:1507 ||| IN
conservative  ||| S:1507 E:1520 ||| JJ
oxygen  ||| S:1520 E:1527 ||| NN
therapy  ||| S:1527 E:1535 ||| NN
in  ||| S:1535 E:1538 ||| IN
patients  ||| S:1538 E:1547 ||| NNS
admitted  ||| S:1547 E:1556 ||| VBD
to  ||| S:1556 E:1559 ||| TO
ICU  ||| S:1559 E:1563 ||| NNP
for  ||| S:1563 E:1567 ||| IN
MV  ||| S:1567 E:1570 ||| NNP
support  ||| S:1570 E:1578 ||| NN
after  ||| S:1578 E:1584 ||| IN
cardiac  ||| S:1584 E:1592 ||| JJ
arrest  ||| S:1592 E:1599 ||| NN
( ||| S:1599 E:1600 ||| -LRB-
Trial  ||| S:1600 E:1606 ||| NNP
registration ||| S:1606 E:1618 ||| NN
,  ||| S:1618 E:1620 ||| ,
NCT01684124 ||| S:1620 E:1631 ||| CD
) ||| S:1631 E:1632 ||| -RRB-
.  ||| S:1632 E:1634 ||| .
